VectorXcellerator Programme: Fully funded feasibility studies to support early-stage cell and gene therapy programmes

Webinar: Optimising viral vector manufacturing with CDMO expertise and innovation

News: OXB honoured at 2025 CDMO Leadership Awards Europe in ‘Cell & Gene Therapy’ category

Resources library

Welcome to our resource library. We invite you to explore and view our extensive resources and information.

2025

AAV: Addressing AAV Manufacturing Challenges

4 November, 2025 | AAV

This brochure demonstrates how OXB addresses AAV manufacturing challenges with robust upstream, downstream, analyics and Regulatory services.

View PDF >
AAV: Addressing AAV Manufacturing Challenges
Brochures
Posters & Presentations2025

Accelerate Time to Clinic: A Platform and Analytics Approach

4 November, 2025 | AAV, Upstream Innovation, Downstream Innovation, Analytics, Regulatory View PDF >
White Papers2025

Achieving rAAV Bioreactor Titer of 1E15 vgL With Novel Plasmid Transient Transfection Platform

4 November, 2025 | AAV View PDF >
Posters & Presentations2025

Advanced Nuclease Applications in Lentiviral Vector Bioprocessing for Superior Downstream Recovery and Vector Product Quality

4 November, 2025 | Lentivirus View PDF >

How to avoid preclinical risk by getting lentiviral decisions right in discovery

23 March, 2026 | Lentivirus

Practical guidance for discovery teams making lentiviral decisions that shape programme success.

View details >
White Papers

Efficient In Vivo Generation of CAR T Cells using a Retargeted Fourth-Generation Lentiviral Vector

23 October, 2025 | Lentivirus View details >
Articles

The TetraVecta™ System: Optimisation & Exemplification of OXB’s Next Generation Lentiviral Vector

15 October, 2025 | Lentivirus View PDF >
Posters & Presentations

Development and Scale Up of Next Generation Lentiviral Vector Batch Process Demonstrating Increased Productivity and Enhanced Purity

15 October, 2025 | Lentivirus View PDF >
Posters & Presentations

What’s Upstream of Downstream Matters: Utilising High-Efficiency Secreted Nuclease (SecNuc™ Enzyme) and Transgene Repression (TRiP System™) to Improve rAAV Production

15 October, 2025 | AAV View PDF >
Posters & Presentations

Case Study: Tech transfer across borders: transferring lentivirus manufacture from the UK to France

18 September, 2025 | Lentivirus View Case Study >
Case Studies